as on 29 Jul 2025, 04:01 PM IST
| Source : NSE
Get live Vimta Labs share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 46.54 % |
3 Month Return | + 27 % |
1 Year Return | + 143.65 % |
3 Year Return | + 237.59 % |
5 Year Return | + 1231.11 % |
Market Stats | |
Previous Close | ₹658.90 |
Open | ₹671.95 |
Volume | 2.57Cr |
Upper Circuit | ₹790.65 |
Lower Circuit | ₹527.15 |
Check Vimta Labs market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹2,932.47 Cr
Return on Equity (ROE)
19.44
PE Ratio (TTM)
47.66
Return on capital employed (ROCE)
24.14
Industry PE ratio
104.31
Beta (LTM)
0.83
P/B Ratio
5.87
Dividend Yield
0PEG Ratio
9.59
Quarterly Earnings Growth YOY
53.83
EPS (TTM)
9.2502312557814
Sector
Healthcare
Book Value
72.1
Technical Analysis
Bullish
View Technical Analysis
Track how Vimta Labs P/E has moved over time to understand its valuation trends.
Vimta Labs in the last 5 years
Lowest (13.76x)
March 20, 2023
Today (47.66x)
July 28, 2025
Industry (104.31x)
July 28, 2025
Highest (47.66x)
July 28, 2025
Today’s Price to Earnings Ratio: 47.66x
Get the annual and quarterly financial summary of Vimta Labs Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Vimta Labs.
Vimta Labs Ltd’s net profit jumped 53.83% since last year same period to ₹18.89Cr in the Q1 2025-2026. On a quarterly growth basis, Vimta Labs Ltd has generated 3.11% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Vimta Labs Ltd has declared dividend of ₹2.00 - translating a dividend yield of 0.61%.
Read More about DividendsCheck stock indices that include Vimta Labs.
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Vimta Labs.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 36.67% | ||
Foreign Institutions | 3.49% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 58.42% | 0.38 | |
Others | 1.42% |
Compare market cap, revenue, PE, and other key metrics of Vimta Labs with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 2,932.47 | 246.22% | 0.54 | 41 | 318 | |
NA | 299.21 | 21.57% | 0.66 | 16 | 135 | |
BUY | 29,861.91 | 67.89% | 0.61 | 211 | 3,698 | |
NA | 1,035.20 | 43.95% | 0.68 | 30 | 177 | |
BUY | 1,973.42 | -10.94% | 0.66 | 42 | 296 |
Latest news and events in one place to help you make informed investing decisions in Vimta Labs.
Vimta Labs Announces Bonus Issue and Dividend - 12 Jun, 2025
Vimta Labs Declares Dividend and Bonus Issue - 27 May, 2025
Vimta Labs Allocates Shares Under ESOP - 23 May, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, VIMTALABS stock has moved up by 27.1%
Best in 1 Year
In the last 1 year, VIMTALABS has outperformed top 5 stocks with highest market-cap in Biotechnology & Medical Research
Revenue Rich
Revenue is up for the last 5 quarters, 75.57 Cr → 99.31 Cr (in ₹), with an average increase of 6.5% per quarter
Profit Spike
Netprofit is up for the last 3 quarters, 12.28 Cr → 21.5 Cr (in ₹), with an average increase of 24.3% per quarter
Best in 3 Years
In the last 3 years, VIMTALABS has outperformed top 5 stocks with highest market-cap in Biotechnology & Medical Research
Retail Holding Up
Retail Investor have increased holdings from 58.20% to 58.42% in Jun 2025 quarter
Promoter Holding Down
Promoters have decreased holdings from 36.70% to 36.67% in Jun 2025 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 3.66% to 3.49% in Jun 2025 quarter
Organisation | Vimta Labs Ltd |
Industry | Healthcare |
CEO | S P Vasireddi |
E-voting on shares | Click here to vote |
Check out the Mutual Funds with significant holdings in Vimta Labs.
Funds | Holdings | Prev. 5M |
---|---|---|
Bandhan BSE Healthcare Index Fund Direct Growth | 0.05% |
Vimta Labs share price today stands at ₹710.3, Open: ₹671.95, Previous Close: ₹658.9, High: ₹721.5, Low: ₹659.5, 52 Week High: ₹721.5, 52 Week Low: ₹242.05 as on 29 Jul 2025, 04:01 PM IST.
To buy Vimta Labs shares, you need to follow these steps:
Today's traded volume of Vimta Labs is 2.57Cr. Which means that 2.57Cr shares of Vimta Labs were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Vimta Labs is ₹2,932.47 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Vimta Labs’s 52 week high is ₹721.5 and 52 week low is ₹242.05. The current share price of Vimta Labs is ₹710.3, which is -1.55% down from its 52 week high and 193.45% up from its 52 week low.